title: [Rho-kinase inhibitors].
authors: seto.mb@om.asahi-kasei.co.jp
authors: Minoru
authors: M
authors: Seto
authors: Toshio
authors: T
authors: Asano
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000577:Amides / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000209:etiology; D015195:Drug Design; D005901:Glaucoma / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000209:etiology; D051379:Mice; D058990:Molecular Targeted Therapy; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D020301:Vasospasm, Intracranial / Q000188:drug therapy / Q000209:etiology; D054460:rho-Associated Kinases / Q000037:antagonists & inhibitors* / Q000502:physiology*
chemical_list: D000577:Amides; D011725:Pyridines; C108830:Y 27632; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; C515851:ROCK1 protein, human; C515852:ROCK2 protein, human; D054460:rho-Associated Kinases; C049347:fasudil